Navigation Links
Are research participants safe enough?
Date:4/26/2010

Every year, millions of patients worldwide participate in randomized clinical trials hoping to benefit from an experimental treatment or potentially help someone else with the same condition.

However, rules and regulations are becoming a menace to academic clinical trials where resources are limited and risks may be much less than those associated with new experimental drugs.

"There is no question that research participants need protection," write Paul Hbert, Editor-in-Chief, CMAJ, and coauthors. "But regulations have grown so burdensome that they are overwhelming the very things they are meant to support and safeguard. Consequently, clinical research has been substantially decreased among industrialized countries."

International bodies, regulatory authorities, the academic community and major granting agencies need to work together to develop and adopt proper, study-specific standards instead of having ineffective monitoring of all clinical research.

The authors conclude that without significant changes, our academic research enterprise and eventually even commercial trials will be immobilized by increasing bureaucracy and spiraling costs.


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Page: 1

Related medicine news :

1. Scientific meeting will host new research in childrens ear, nose and throat health
2. Los Angeles Plastic Surgeon is the New President of the Aesthetic Surgery and Research Foundation (ASERF)
3. Cancer research award to Johns Hopkins basic scientist
4. Parkinson's Disease Patient's Story Goes Multimedia, Proceeds to Benefit PD Research
5. Nutrition researchers to develop new growth charts for children with Down syndrome
6. MU researchers show potential for new cancer detection and therapy method
7. Provalis Research Announces the Release of WordStat 6, Delivering Enhanced Analytical and Visualization Tools for Textual Data
8. Researchers successfully lower radiation dose associated with pediatric chest CT scans
9. Researchers identify a new breast and ovarian cancer susceptibility gene
10. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
11. Lombardi research teams hone in on treatments for osteosarcoma and Ewings sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Newark, NJ (PRWEB) , ... April 28, 2017 , ... ... Poor’s has affirmed the company’s credit rating of “A” and its outlook as “stable.” ... downgraded if capital reserves, which have fallen in recent years, dip below “capital adequacy” ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today a ... the Northeast U.S. , GlycoMark is the only clinically available blood test ... a clinically proven one- to two-week measure of hyperglycemic excursions, often related to ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... Replace tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent ... rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. Datta. ... certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and used ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... CITY, Calif. , April 24, 2017 ... durability, grip, protection, and comfort, announces the release of ... Powerform S8+. This most recent example of leading edge ... density grip pattern for 200% more tactile grip on ... user protection and durability. With TracTek and a suite ...
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
Breaking Medicine Technology: